Cardio-HART (the device for diagnosis of heart troubles)

2020: Announcement of Cardio-HART - The AI device diagnosing 95% of heart troubles

In the middle of December, 2020 the Cardio-Phoenix company released the AI device for diagnosis of cardiovascular diseases. According to developers, a new system is capable to reveal 95% of the most widespread heart troubles.

According to the press release, the Cardio-HART system (or, shortly, Chart) combines the device for registration of physiological biosignals of heart with the cloud mechanism of the diagnostic analysis based on artificial intelligence. Cardio-Phoenix stated that a system will provide highly effective cardiological diagnostics, having turned primary health care into "vanguard of the specialized cardiological help".

Cardio-Phoenix released the AI device diagnosing 95% of heart troubles

According to developers, Chart is "the combination of the best opportunities of the ECG, EHO-KS and an auskultation complemented with the analysis based on artificial intelligence". According to the company, Chart is capable to detect and diagnose 95% of all most serious and widespread heart diseases while standard electrocardiographs allow to detect and diagnose only about 44% from them.

Developers counted that universal use of Chart can reduce cardiovascular diseases mortality on 156,000 cases annually among adult population of the USA at the age of ≥40 years. Besides, Chart can be used for the purposes of telemedicine that is especially relevant during COVID-19 pandemic.

Chart provides clinical data which not only represent diagnostic interest, but also help the practicing doctor to make the decision on the direction of the patient to the cardiologist. Besides, this system provides to the cardiologist the relevant information for adoption of clinical solutions of rather additional inspection and treatment, - doctor Stephen Kurtsman, the cardiologist of FDA considers.[1]

Notes